PubRank

M Scheurlen

Author PubWeight™ 36.53‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Therapy of interferon-induced depression in chronic hepatitis C with citalopram: a randomised, double-blind, placebo-controlled study. Gut 2007 1.75
2 Circular dichroism of ribonucleoprotein complexes from rat liver nuclei. Biochem Biophys Res Commun 1977 1.69
3 Pentamidine and hypoglycaemia. Lancet 1989 1.39
4 Emotional state, coping styles, and somatic variables in patients with chronic hepatitis C. Psychosomatics 2000 1.16
5 Anti-Saccharomyces cerevisiae antibodies in inflammatory bowel disease: a family study. Scand J Gastroenterol 2001 1.15
6 Paroxetine for the treatment of interferon-alpha-induced depression in chronic hepatitis C. Aliment Pharmacol Ther 2002 1.13
7 Epidemiology of inflammatory bowel disease in the county of Tübingen (West Germany). Scand J Gastroenterol Suppl 1989 1.08
8 Prophylactic SSRI during interferon alpha re-therapy in patients with chronic hepatitis C and a history of interferon-induced depression. J Viral Hepat 2005 1.07
9 Compliance with therapy in patients with chronic hepatitis C: associations with psychiatric symptoms, interpersonal problems, and mode of acquisition. Dig Dis Sci 2001 1.04
10 Fast-growing gastric inflammatory pseudotumor: a rare manifestation of peptic ulcer disease. Endoscopy 2002 0.98
11 Cavernous transformation of the portal vein associated with common bile duct strictures: report of two cases. Gastrointest Endosc 1998 0.98
12 Successful treatment of a gastric leak after bariatric surgery using endoluminal vacuum therapy. Endoscopy 2013 0.97
13 Oxprenolol absorption in man after single bolus dosing into two segments of the colon compared with that after oral dosing. Br J Clin Pharmacol 1985 0.96
14 Pancreatic autoantibodies in Crohn's disease: a family study. Gut 1997 0.94
15 The basal ganglia in haemochromatosis. Neuroradiology 2000 0.93
16 Reconstitution of squamous epithelium in Barrett's oesophagus with endoscopic argon plasma coagulation: a prospective study. Scand J Gastroenterol 1998 0.92
17 Spectral karyotype analysis of colon cancer cell lines of the tumor suppressor and mutator pathway. Cytogenet Genome Res 2002 0.92
18 Microbic superinfection in relapse of inflammatory bowel disease. J Clin Gastroenterol 1992 0.90
19 Structure and function of nuclear ribonucleoprotein complexes. Rev Physiol Biochem Pharmacol 1978 0.89
20 Expression pattern of gastrointestinal selenoproteins--targets for selenium supplementation. Nutr Cancer 1998 0.88
21 Low molecular weight RNAs as components of nuclear ribonucleoprotein particles containing heterogeneous nuclear RNA. Biochim Biophys Acta 1979 0.87
22 Impaired pancreatic function in patients with Crohn's disease with and without pancreatic autoantibodies. J Clin Gastroenterol 1996 0.85
23 Inverse mRNA expression of the selenocysteine-containing proteins GI-GPx and SeP in colorectal adenomas compared with adjacent normal mucosa. Nutr Cancer 2000 0.84
24 Paroxetine for the prevention of depression induced by interferon alfa. N Engl J Med 2001 0.83
25 [Phlegmonous gastritis in a 44-year-old woman on immunosuppressive therapy]. Dtsch Med Wochenschr 2007 0.82
26 Comparative studies of the effects of galactosamine and actinomycin D on nuclear ribonucleoprotein particles from rat liver. Exp Cell Res 1977 0.81
27 Prevention of hepatitis B flare-up during chemotherapy using lamivudine: case report and review of the literature. Ann Hematol 1999 0.79
28 Neutrophil antibodies (pANCA) in chronic liver disease and inflammatory bowel disease: do they react with different antigens? Eur J Gastroenterol Hepatol 1996 0.78
29 Computed tomography after lymphangiography in the diagnosis of intestinal lymphangiectasia with protein-losing enteropathy in Noonan's syndrome. Eur Radiol 2000 0.78
30 Primary biliary cirrhosis and gastric carcinoid: a rare association? J Clin Gastroenterol 1997 0.78
31 [Managing psychiatric side effects of antiviral therapy in chronic hepatitis C]. Z Gastroenterol 2012 0.78
32 [Liver transplantation in halothane-induced liver necrosis]. Zentralbl Chir 1994 0.78
33 Autoimmune hepatitis in inflammatory bowel disease: report of two unusual cases. Z Gastroenterol 1997 0.77
34 [Newly recognized side-effects of proton pump inhibitors. Arguments in favour of fundoplication for GERD?]. Chirurg 2012 0.76
35 The pancreatitis-associated protein in hereditary and chronic alcoholic pancreatitis. Pancreas 1999 0.76
36 Studies on the preparation and properties of ribonucleoprotein particles from rat liver nuclei. Biochim Biophys Acta 1978 0.76
37 Endoscopic laser therapy in a case of gastric antral vascular ectasia (watermelon stomach). Z Gastroenterol 1993 0.76
38 Sexual dysfunction in males with chronic hepatitis C and antiviral therapy: interferon-induced functional androgen deficiency or depression? J Endocrinol 2005 0.75
39 [Successful therapy of persistent androgen-induced cholestasis with ursodeoxycholic acid]. Z Gastroenterol 1997 0.75
40 Giant fold gastritis with consecutive gastric carcinoma in a patient with peutz-jeghers syndrome. Z Gastroenterol 2005 0.75
41 [Colorectal cancer screening. How dangerous is colonoscopy? (interview by Dr. Judith Neumaier)]. MMW Fortschr Med 2007 0.75
42 [Clarifying chronic diarrhea. I. Drug-induced side effect and malabsorption]. MMW Fortschr Med 2003 0.75
43 [The role of the diet in the prevention of gastrointestinal tumors]. MMW Fortschr Med 2007 0.75
44 [Differential diagnosis of chronic inflammatory bowel diseases. Value of determination of autoantibodies pANCA, ASCA AND PAB (perinuclear antineutrophil cytoplasmic antibody, antibody against Saccharomyces cerevisiae, antibody against pancreas)]. Fortschr Med 1999 0.75
45 [Methotrexate in the therapy of primary biliary cirrhosis]. Dtsch Med Wochenschr 1991 0.75
46 Decreased responsiveness of platelets to a stable prostacyclin analogue in patients with Crohn's disease. Reversal by n-3 polyunsaturated fatty acids. Thromb Res 1991 0.75
47 [Peptic ulcer hemorrhage: i.v. antacid prevents recurrence]. MMW Fortschr Med 2000 0.75
48 [Sports and the digestive system]. Internist (Berl) 1992 0.75
49 [Hereditary nonpolyposis colorectal carcinoma (HNPCC). Current review of etiology, clinical aspects, diagnosis and therapy]. Med Klin (Munich) 2001 0.75
50 [Indications for surgery in portal hypertension from the internist's viewpoint]. Chirurg 1985 0.75
51 [Diagnosis and treatment of intrahepatic cholestasis syndrome]. MMW Fortschr Med 2004 0.75
52 [Localization and extent of Crohn disease at initial diagnosis]. Med Klin (Munich) 1987 0.75
53 Simple radioligand binding assay for the determination of urinary scopolamine. J Pharm Sci 1984 0.75
54 [Primary glomangioma of the liver. A new differential benign liver tumor diagnosis]. Chirurg 2002 0.75
55 [Rectal bleeding: when is it a sign of colon cancer?]. MMW Fortschr Med 2001 0.75
56 [Decrease of antithrombin III and factor Xa inhibitor as the cause of thromboembolism complications in chronic inflammatory intestinal disease]. Internist (Berl) 1985 0.75
57 Treatment of bile duct stones: value of laser lithotripsy delivered via percutaneous endoscopy. Eur Radiol 1996 0.75
58 [Narrowing of the palpebral fissure as the first symptom of extensive osteoma with orbital involvement]. Klin Monbl Augenheilkd 1992 0.75
59 [A fistula between the rectosigmoid junction and the ileum as a complication of highly malignant AIDS-associated lymphoma]. Dtsch Med Wochenschr 1991 0.75
60 [Vomiting as the main symptom]. Internist (Berl) 1998 0.75
61 [Pathophysiology of small intestine diseases]. Schweiz Rundsch Med Prax 1988 0.75